form8ka.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Amendment No. 1
to
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 26, 2010
Merge Healthcare Incorporated
(Exact name of registrant as specified in its charter)
Delaware
|
39-1600938
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(I.R.S. Employer Identification No.)
|
|
|
900 Walnut Ridge Drive
|
|
Hartland, Wisconsin
|
53029
|
(Address of Principal Executive Offices)
|
(ZIP Code)
|
(262) 367-0700
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
The purpose of this Amendment No. 1 to Current Report on Form 8-K is to amend the Current Report on Form 8-K filed by the Registrant on April 30, 2010 to include the consent of BDO Seidman, LLP.
Item 9.01 Financial Statements and Exhibits
(a).
|
Financial Statements of Businesses Acquired.
|
The financial information set forth in Item 8 of AMICAS, Inc.’s Annual Report on Form 10-K for 2009 filed with the SEC on March 11, 2010 is incorporated herein by reference.
23.1 Consent of BDO Seidman, LLP
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
MERGE HEALTHCARE INCORPORATED
|
|
|
|
|
|
|
June 18, 2010
|
/s/ Steven M. Oreskovich
|
|
|
By: Steven M. Oreskovich
|
|
|
Title: Chief Financial Officer
|
|